The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution
  • Recherche

The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice
  • Recherche

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice

  • Recherche

The Interplay of TLR-NFκB Signalling Pathway and Functional Immune-Related Enzymes in the Inflammatory Response of Ciona robusta

The Interplay of TLR-NFκB Signalling Pathway and Functional Immune-Related Enzymes in the Inflammatory Response of Ciona robusta
  • Recherche

The Interplay of TLR-NFκB Signalling Pathway and Functional Immune-Related Enzymes in the Inflammatory Response of Ciona robusta

Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1
  • Recherche

Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1

The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial
  • Clinic

The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial

A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses
  • Recherche

A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses

A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off
  • Recherche

A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer
  • Clinic

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma
  • Recherche

Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
  • Clinic

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
  • Clinic

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas